Get the Stockscreener App
6.51
0.61%
-0.04
Mimedx Group Inc stock is traded at $6.51, with a volume of 502.31K.
It is down -0.61% in the last 24 hours and down -6.20% over the past month.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$6.55
Open:
$6.58
24h Volume:
502.31K
Relative Volume:
0.72
Market Cap:
$963.22M
Revenue:
$342.81M
Net Income/Loss:
$97.67M
P/E Ratio:
10.59
EPS:
0.6145
Net Cash Flow:
$50.46M
1W Performance:
-10.94%
1M Performance:
-6.20%
6M Performance:
-4.82%
1Y Performance:
+14.01%
1-Day Range:
$6.45
$6.6585
1-Week Range:
$6.45
$7.35
52-Week Range:
$5.585
$10.14
Mimedx Group Inc Stock (MDXG) Company Profile
Name
Mimedx Group Inc
Sector
Industry
Phone
(770) 651-9100
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
4.2701 | 5.31B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
19.91 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.55 | 113.25M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2028 | 445.05M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.0001 | 0 | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-02-24 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-24 | Initiated | Lake Street | Buy |
| Oct-27-23 | Initiated | Craig Hallum | Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-26-21 | Initiated | Northland Capital | Outperform |
| Mar-19-21 | Initiated | H.C. Wainwright | Buy |
View All
Mimedx Group Inc Stock (MDXG) Latest News
Is MiMedx Group Inc. stock a buy for dividend growthAnalyst Upgrade & Accurate Intraday Trade Tips - newser.com
Volume spikes in MiMedx Group Inc. stock – what they mean2025 Winners & Losers & Low Risk Entry Point Guides - newser.com
Why MiMedx Group Inc. stock appeals to dividend seekersBuy Signal & Community Verified Watchlist Alerts - newser.com
MiMedx Group Inc. stock momentum explainedMarket Performance Report & Free Long-Term Investment Growth Plans - newser.com
Will MiMedx Group Inc. stock outperform growth indexesJuly 2025 Chart Watch & Daily Market Momentum Tracking - newser.com
Why analysts upgrade MiMedx Group Inc. stockQuarterly Earnings Summary & Free Weekly Watchlist of Top Performers - newser.com
Will MiMedx Group Inc. stock reach Wall Street targetsJuly 2025 Highlights & Real-Time Volume Analysis - newser.com
Relative strength of MiMedx Group Inc. in sector analysisQuarterly Performance Summary & Technical Entry and Exit Tips - newser.com
Using economic indicators to assess MiMedx Group Inc. potentialQuarterly Profit Summary & Low Risk Entry Point Tips - newser.com
Earnings visualization tools for MiMedx Group Inc.2025 Market Outlook & Weekly Top Gainers Alerts - newser.com
MiMedx Group (NASDAQ:MDXG) Given "Hold (C)" Rating at Weiss Ratings - MarketBeat
How to interpret RSI for MiMedx Group Inc. stockCEO Change & Daily Market Momentum Tracking - newser.com
What data driven models say about MiMedx Group Inc.’s futureMarket Performance Report & Reliable Breakout Forecasts - newser.com
Why analysts remain bullish on MiMedx Group Inc. stockJuly 2025 Drop Watch & Long-Term Safe Return Strategies - newser.com
Is MiMedx Group Inc. stock a top pick in earnings seasonCEO Change & Low Risk High Win Rate Picks - newser.com
Amniotic Membrane Market Projections 2025-2032: Key Trends, - openPR.com
MIMEDX Announces Launch of EPIXPRESS® - Sahm
MiMedx launches fenestrated placental allograft for wound care By Investing.com - Investing.com Nigeria
MiMedx Group Hits Day High with Strong 7.45% Intraday Surge - Markets Mojo
MiMedx (MDXG) Unveils EPIXPRESS for Advanced Wound Care - GuruFocus
MiMedx launches fenestrated placental allograft for wound care - Investing.com
MiMedx Group, Inc. Launches EPIXPRESS® to Enhance Wound Care Solutions - Quiver Quantitative
Lyophilized, Fenestrated Tri‑Layer Graft — MiMedx Launches EPIXPRESS for DFUs, VLUs and Deep Wounds - Stock Titan
How moving averages guide MiMedx Group Inc. tradingInflation Watch & Verified Stock Trade Ideas - newser.com
What insider trading reveals about MiMedx Group Inc. stockMarket Weekly Review & Fast Entry High Yield Stock Tips - newser.com
Signal strength of MiMedx Group Inc. stock in tech scannersEarnings Overview Summary & Safe Entry Point Identification - newser.com
Technical analysis overview for MiMedx Group Inc. stockSell Signal & Capital Efficiency Focused Ideas - newser.com
Published on: 2025-10-03 07:06:45 - newser.com
Published on: 2025-10-03 05:17:01 - newser.com
Order flow analysis tools used on MiMedx Group Inc.Quarterly Profit Report & Reliable Trade Execution Plans - newser.com
What analysts say about MiMedx Group Inc stockIPO Market Watch & Learn to Think Like a Long-Term Investor - earlytimes.in
Published on: 2025-09-29 11:25:10 - newser.com
Mimedx Group Inc Stock (MDXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mimedx Group Inc Stock (MDXG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Maersk-Moller Kimberly | Chief Commercial Officer |
Mar 17 '25 |
Sale |
8.04 |
1,759 |
14,142 |
309,077 |
| Hulse William Frank IV | General Counsel and CAO |
Mar 13 '25 |
Sale |
7.89 |
54,596 |
430,762 |
440,178 |
| Maersk-Moller Kimberly | Chief Commercial Officer |
Mar 13 '25 |
Sale |
7.89 |
4,106 |
32,396 |
310,836 |
| Hulse William Frank IV | General Counsel and CAO |
Mar 10 '25 |
Sale |
7.80 |
81,446 |
635,279 |
494,774 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):